Phase II study of hydroxyurea administered intermittently in malignant melanoma. 1970

H J Lerner, and G L Beckloff, and M C Godwin

UI MeSH Term Description Entries
D007958 Leukocyte Count The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells. Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D007970 Leukopenia A decrease in the number of LEUKOCYTES in a blood sample below the normal range (LEUKOCYTE COUNT less than 4000). Leukocytopenia,Leukocytopenias,Leukopenias
D008297 Male Males
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009362 Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006918 Hydroxyurea An antineoplastic agent that inhibits DNA synthesis through the inhibition of ribonucleoside diphosphate reductase. Hydroxycarbamid,Hydrea,Oncocarbide

Related Publications

H J Lerner, and G L Beckloff, and M C Godwin
May 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
H J Lerner, and G L Beckloff, and M C Godwin
January 1994, European journal of cancer (Oxford, England : 1990),
H J Lerner, and G L Beckloff, and M C Godwin
January 1978, Medical and pediatric oncology,
H J Lerner, and G L Beckloff, and M C Godwin
June 1992, American journal of clinical oncology,
H J Lerner, and G L Beckloff, and M C Godwin
January 1999, The Journal of urology,
H J Lerner, and G L Beckloff, and M C Godwin
January 1994, European journal of cancer (Oxford, England : 1990),
H J Lerner, and G L Beckloff, and M C Godwin
December 1985, Cancer treatment reports,
H J Lerner, and G L Beckloff, and M C Godwin
January 1984, Investigational new drugs,
H J Lerner, and G L Beckloff, and M C Godwin
January 1981, Cancer treatment reports,
H J Lerner, and G L Beckloff, and M C Godwin
January 1985, Cancer treatment reports,
Copied contents to your clipboard!